Immediate Impact
5 from Science/Nature 52 standout
Citing Papers
The cancer-immunity cycle: Indication, genotype, and immunotype
2023 Standout
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
2022 Standout
Works of A. Spada being referenced
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer
2006
Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized study
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Spada | 227 | 93 | 63 | 177 | 17 | 418 | |
| Eo-Jin Kim | 243 | 124 | 76 | 226 | 10 | 468 | |
| David F. Dexter | 197 | 142 | 96 | 108 | 20 | 451 | |
| Elisabetta Setola | 189 | 91 | 59 | 310 | 25 | 457 | |
| Coralie Moncharmont | 199 | 155 | 46 | 152 | 26 | 424 | |
| Abha Soni | 281 | 125 | 19 | 136 | 22 | 493 | |
| Luis Buelta | 140 | 98 | 112 | 107 | 24 | 399 | |
| Jeannette Soria | 157 | 91 | 114 | 80 | 11 | 410 | |
| Anita Rodenas | 195 | 63 | 49 | 123 | 12 | 379 | |
| Sanjeev Gill | 340 | 83 | 114 | 114 | 24 | 472 | |
| H Wang | 183 | 161 | 81 | 95 | 16 | 481 |
All Works
Loading papers...